CXCL1/CXCR2 signaling in pathological pain: Role in peripheral and central sensitization
- PMID: 28587921
- DOI: 10.1016/j.nbd.2017.06.001
CXCL1/CXCR2 signaling in pathological pain: Role in peripheral and central sensitization
Abstract
Pathological pain conditions can be triggered after peripheral nerve injury and/or inflammation. It is associated with plasticity of nociceptive pathway in which pain is prolonged even after healing of the injured tissue. Generally combinations of analgesic drugs are not sufficient to achieve selective palliation from chronic pain, besides causing a greater number of side effects. In order to identify novel alternatives for more effective treatments, it is necessary to clarify the underlying mechanisms of pathological pain. It is well established that there are two main components in pathological pain development and maintenance: (i) primary sensory neuron sensitization (peripheral sensitization), and (ii) central sensitization. In both components cytokines and chemokines act as key mediators in pain modulation. CXCL1 is a chemokine that promote both nociceptor and central sensitization via its main receptor CXCR2, which is a promising target for novel analgesic drugs. Here, we reviewed and discussed the role of the CXCL1/CXCR2 signaling axis in pathological pain conditions triggered by either peripheral inflammation or nerve injury.
Keywords: CXCL1; CXCR2; Chemokine; Inflammatory pain; Neuropathic pain.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Levo-corydalmine alleviates vincristine-induced neuropathic pain in mice by inhibiting an NF-kappa B-dependent CXCL1/CXCR2 signaling pathway.Neuropharmacology. 2018 Jun;135:34-47. doi: 10.1016/j.neuropharm.2018.03.004. Epub 2018 Mar 5. Neuropharmacology. 2018. PMID: 29518397
-
Chemokine receptor CXCR2 in dorsal root ganglion contributes to the maintenance of inflammatory pain.Brain Res Bull. 2016 Oct;127:219-225. doi: 10.1016/j.brainresbull.2016.09.016. Epub 2016 Sep 30. Brain Res Bull. 2016. PMID: 27697507
-
The role of CXCL1/CXCR2 axis in neurological diseases.Int Immunopharmacol. 2023 Jul;120:110330. doi: 10.1016/j.intimp.2023.110330. Epub 2023 May 27. Int Immunopharmacol. 2023. PMID: 37247498 Review.
-
Spinal blockage of CXCL1 and its receptor CXCR2 inhibits paclitaxel-induced peripheral neuropathy in mice.Neuropharmacology. 2019 Jun;151:136-143. doi: 10.1016/j.neuropharm.2019.04.014. Epub 2019 Apr 13. Neuropharmacology. 2019. PMID: 30991054
-
Neuropathic Pain: Sensory Nerve Injury or Motor Nerve Injury?Adv Exp Med Biol. 2016;904:59-75. doi: 10.1007/978-94-017-7537-3_5. Adv Exp Med Biol. 2016. PMID: 26900063 Review.
Cited by
-
CXCL1 Regulated by miR-302e Is Involved in Cell Viability and Motility of Colorectal Cancer via Inhibiting JAK-STAT Signaling Pathway.Front Oncol. 2021 May 17;10:577229. doi: 10.3389/fonc.2020.577229. eCollection 2020. Front Oncol. 2021. PMID: 34079750 Free PMC article.
-
TRAF6 promotes spinal microglial M1 polarization to aggravate neuropathic pain by activating the c-JUN/NF-kB signaling pathway.Cell Biol Toxicol. 2024 Jul 12;40(1):54. doi: 10.1007/s10565-024-09900-6. Cell Biol Toxicol. 2024. PMID: 38995476 Free PMC article.
-
An Update on the Chemokine System in the Development of NAFLD.Medicina (Kaunas). 2022 Jun 5;58(6):761. doi: 10.3390/medicina58060761. Medicina (Kaunas). 2022. PMID: 35744024 Free PMC article. Review.
-
ATRPred: A machine learning based tool for clinical decision making of anti-TNF treatment in rheumatoid arthritis patients.PLoS Comput Biol. 2022 Jul 5;18(7):e1010204. doi: 10.1371/journal.pcbi.1010204. eCollection 2022 Jul. PLoS Comput Biol. 2022. PMID: 35788746 Free PMC article.
-
Inhibition of CXCR2 alleviates the development of abdominal aortic aneurysm in Apo E-/- mice.Acta Cir Bras. 2021 Feb 15;36(1):e360105. doi: 10.1590/ACB360105. eCollection 2021. Acta Cir Bras. 2021. PMID: 33605308 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical